Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Indo Global Exchange(s) PTE, Ltd. IGEX OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • ID • USD

SharesGrow Score
17/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Indo Global Exchange(s) PTE, Ltd. (IGEX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 16/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $751,000 (loss), growing at -363.5%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $6M against $150,887 equity (Debt-to-Equity (D/E) ratio 41.95, leveraged). Current ratio is 0.92 (tight liquidity). Debt-to-assets is 94.3%. Total assets: $7M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

IGEX SharesGrow Score Overview

23/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — IGEX

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
IGEX: +0%/yr revenue is, -363.5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
IGEX: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
28/100
IGEX: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0002-0.0007
Volume2.23M
Avg Volume (30D)12.82M
Market Cap$2.64M
Beta (1Y)1.65
Share Statistics
EPS (TTM)0.00
Shares Outstanding$6.11B
IPO Date2013-05-29
CEOSergio Bellosta Suarez
Financial Highlights & Ratios
EBITDA$-750K
Net Income$-751K
Operating Income$-188K
Total Debt$6.33M
Net Debt$6.33M
Total Assets$6.71M
Price / Earnings (P/E)-6
Analyst Forecast
Company Info
CountryID
ExchangeOther OTC
CurrencyUSD
ISINUS45579B1017

Price Chart

Track all markets on TradingView
IGEX
Indo Global Exchange(s) PTE, Ltd. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

AVCNF
AVCNF
Avicanna Inc.
$0.11
-2.06%
 MGCLF
MGCLF
MGC Pharmaceuticals Limited
$0.27
+2.88%
 ABTI
ABTI
Alterola Biotech, Inc.
$0.01
+0.00%
 CHNC
CHNC
China Infrastructure Construction Corp.
$0.00
+14.94%
 CBDNF
CBDNF
CBD Global Sciences Inc.
$0.04
-2.67%
 CBDY
CBDY
Target Group Inc.
$0.00
+0.00%
 CNNA
CNNA
Cann American Corp.
$0.00
+0.00%
 HBRM
HBRM
Herborium Group, Inc.
$0.00
+9,900.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message